Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

24.21EUR
14 Jun 2019
Change (% chg)

€0.00 (+0.00%)
Prev Close
€24.21
Open
€24.09
Day's High
€24.31
Day's Low
€24.09
Volume
463,168
Avg. Vol
646,305
52-wk High
€27.68
52-wk Low
€21.57

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.62
Market Cap(Mil.): €14,802.66
Shares Outstanding(Mil.): 687.55
Dividend: 0.15
Yield (%): 1.43

Financials

  GRLS.MC Industry Sector
P/E (TTM): 29.14 32.88 37.45
EPS (TTM): 0.83 -- --
ROI: 5.23 12.53 12.16
ROE: 14.00 13.82 16.93

Spain's Grifols, China's Shanghai RAAS form strategic alliance

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

Mar 07 2019

Spain's Grifols, China's Shanghai RAAS form strategic alliance

March 7 Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

Mar 07 2019

Earnings vs. Estimates